Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2
Completed
- Conditions
- Esophageal Cancer
- Interventions
- Other: immunohistochemistry staining methodRadiation: radiation therapy
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 22
- Registration Number
- NCT00524121
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Not Applicable
Withdrawn
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00524069
Vitamin D in Treating Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Dietary Supplement: cholecalciferol
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 148
- Registration Number
- NCT00524680
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Phase 2
Terminated
- Conditions
- Breast Cancer
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2014-08-29
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 6
- Registration Number
- NCT00524459
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Not Applicable
Terminated
- Conditions
- Precancerous/Nonmalignant Condition
- Interventions
- Procedure: laser therapy
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 12
- Registration Number
- NCT00524485
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Phase 2
Terminated
- Conditions
- Liver Cancer
- Interventions
- Other: laboratory biomarker analysisProcedure: hepatic artery embolizationProcedure: quality-of-life assessment
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 16
- Registration Number
- NCT00524316
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Phase 1
Completed
- Conditions
- Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal CavityRecurrent Inverted Papilloma of the Paranasal Sinus and Nasal CavityRecurrent Lymphoepithelioma of the NasopharynxRecurrent Lymphoepithelioma of the OropharynxRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal CavityRecurrent Mucoepidermoid Carcinoma of the Oral CavityRecurrent Salivary Gland Cancer
- Interventions
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT00470496
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
Phase 2
Completed
- Conditions
- Esophageal Cancer
- Interventions
- Genetic: gene expression analysisGenetic: microarray analysisGenetic: reverse transcriptase-polymerase chain reactionProcedure: adjuvant therapyProcedure: biopsyProcedure: conventional surgeryProcedure: neoadjuvant therapyProcedure: quality-of-life assessmentRadiation: radiation therapy
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 41
- Registration Number
- NCT00470184
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery
Not Applicable
Terminated
- Conditions
- Colorectal Cancer
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 8
- Registration Number
- NCT00470353
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Phase 2
Terminated
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 9
- Registration Number
- NCT00470067
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States